Conjugation of IR700 to epidermal growth factor receptors (EGFR)—targeting panitumumab (Pan-IR700) showed selective uptake in EGFR expressing A431 cells and effective tumor shrinkage after irradiation was observed in EGFR expressing A431 tumors (Figure 3). This evidence concerns the gene EGFR and neoplasm.